| abstract |
An agent for preventing and/or treating conditions that start with a disturbance of bone formation contains alkaline citrates, lactates and/or malates, optionally together with one or several active substances selected among vitamin K, calcium salts and vitamin D. The agent preferably contains potassium and/or sodium citrates and/or lactates, and is useful for preventing and/or treating bone demineralisation, in particular osteoporosis or osteomalacia. |